Home › Funds › PFM Health Sciences, LP › IWM
PFM Health Sciences, LP position in IWM
ISHARES TR
PFM Health Sciences, LP reported holding 45,300 shares of IWM (ISHARES TR) in its Q3 2026 13F filing — a position valued at US$12.6M, representing 1.29% of its reported portfolio and ranking #29 among its reported holdings. PFM Health Sciences, LP has disclosed IWM holdings in 5 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How PFM Health Sciences, LP's IWM position evolved
PFM Health Sciences, LP first disclosed a stake in IWM in Q1 2024 at 187,715 shares (US$39.5M). Across 5 filings, PFM Health Sciences, LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 45,300 shares valued at US$12.6M. Notable position changes include a 62% trim in Q2 2024 (shares rose 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 187.72K | $39.48M | New |
| Q2 2024 | 70.70K | $14.34M | Reduce |
| Q4 2024 | 54.80K | $12.11M | New |
| Q3 2025 | 56.70K | $13.72M | New |
| Q3 2026 | 45.30K | $12.59M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IWM and 13F data
IWM (ISHARES TR) is a company whose sector is not yet classified in our data. 27 other funds we track also report a position in IWM — the largest reported positions include Millennium Management (US$14.51B), Bank of America Corp (US$10.75B), Empower Advisory Group, LLC (US$2.23B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IWM
- Millennium Management 48.29M sh · $14.51B · Q2 2026
- Bank of America Corp 38.67M sh · $10.75B · Q3 2026
- Empower Advisory Group, LLC 8.01M sh · $2.23B · Q3 2026
- ARMISTICE CAPITAL, LLC 6.60M sh · $1.83B · Q3 2026
- Treasurer of the State of North Carolina 5.93M sh · $1.78B · Q2 2026
- Citigroup Inc 6.31M sh · $1.75B · Q3 2026
- BNP PARIBAS FINANCIAL MARKETS 6.05M sh · $1.68B · Q3 2026
- SUSQUEHANNA INTERNATIONAL GROUP, LLP 4.97M sh · $1.49B · Q2 2026
- Luxor Capital Group, LP 4.60M sh · $1.28B · Q3 2026
- BARCLAYS PLC 4.51M sh · $1.25B · Q3 2026
- ROYAL BANK OF CANADA 4.28M sh · $1.19B · Q3 2026
- Wells Fargo & Co 3.90M sh · $1.17B · Q2 2026
More on PFM Health Sciences, LP
FAQ
How long has PFM Health Sciences, LP held IWM?
PFM Health Sciences, LP has disclosed IWM holdings in 5 of the last 11 reported quarters, going back to Q1 2024.
What is PFM Health Sciences, LP's current position in IWM?
As of Q3 2026, PFM Health Sciences, LP holds 45.30K shares of IWM (ISHARES TR), valued at $12.59M, representing 1.29% of its reported portfolio and ranking #29.
Has PFM Health Sciences, LP been buying or selling IWM?
In the latest 13F filing (Q3 2026), PFM Health Sciences, LP newly opened its position in IWM.
Which other funds hold IWM?
Other major institutional holders of IWM include Millennium Management, Bank of America Corp, Empower Advisory Group, LLC, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.